Explainer on Zepbound's FDA approval and what its regulatory status means
An evergreen overview of where Zepbound stands with the FDA and what the approval means for people considering it.
Recap by typeshit. Full story at ΕΜΥ.
An evergreen overview of where Zepbound stands with the FDA and what the approval means for people considering it.
Recap by typeshit. Full story at ΕΜΥ.
TIKR points to retatrutide, due for filing in early 2027, and says a pending Seventh Circuit ruling on whether it counts as a biologic could decide 5 vs 12 years of exclusivity.
She lost 7 kilos in her first month, regained it during a month-long break, and now says she's eating more and gaining in week two back.
A shared report on doctors turning to GLP-1 medications for weight loss in some kids. Details are thin, so tap through for the full story.
The author, who holds Novo shares, cites Morgan Stanley's $190 billion obesity market forecast for 2035 and an NIH-funded mouse study on aging.
Prescriptions roll out in phases from the 29th, starting at 129,800 won for four weeks. Hanmi reported 9.75% average weight loss at 40 weeks in a phase 3 interim analysis.
Facial fat loss during GLP-1 weight loss can mean hollowing, flatter cheeks and looser skin, and Dr. Makkani says creams won't solve all of it.
Loading…